The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. Elsevier’s Current Opinion journals comprise of 26 leading titles in life sciences and adjacent fields.

Current Opinion in Virology

IMPACT FACTOR: 5.644
5-Year Impact Factor: 5.376
Issues per year: 6 issues
Editorial Board

Current Opinion in Virology

Current Opinion in Virology is a new systematic review journal that aims to provide specialists with a unique and educational platform to keep up to date with the expanding volume of information published in the field of virology. It will consist of 6 issues per year covering the following 11 sections, each of which is reviewed once a year:

Emerging viruses: interspecies transmission
Viral immunology
Viral pathogenesis
Preventive and therapeutic vaccines
Antiviral strategies
Virus structure and expression
Animal models for viral diseases
Engineering for viral resistance
Viruses and cancer
Virus vector interactions

There is also a section that changes every year to reflect hot topics in the field.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.

Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Best Cited over the last year.

Subscribe to RSS Sciverse Scopus

Zoonotic origin of hepatitis e

Volume 10, Issue , 01 January 2015, Pp 34-41
Nicole Pavio | Xiang Jin Meng | Virginie Doceul

RIG-I-like receptor regulation in virus infection and immunity

Volume 12, Issue , 01 January 2015, Pp 7-14
Ying Kai Chan | Michaela U. Gack

Current status and prospects of HIV treatment

Volume 18, Issue , 01 June 2016, Pp 50-56
Tomas Cihlar | Marshall Fordyce

Structural insights into viral IRES-dependent translation mechanisms

Volume 12, Issue , 14 June 2015, Pp 113-120
Gloria Lozano | Encarnación Martínez-Salas

Functions of the influenza A virus NS1 protein in antiviral defense

Volume 12, Issue , 01 January 2015, Pp 1-6
Robert M. Krug

Kaposi Sarcoma-associated Herpesvirus: Mechanisms of oncogenesis

Volume 14, Issue , 01 October 2015, Pp 116-128
Thomas F. Schulz | Ethel Cesarman

How RIG-I like receptors activate MAVS

Volume 12, Issue , 14 June 2015, Pp 91-98
Bin Wu | Sun Hur

Inflammasome control of viral infection

Volume 12, Issue , 01 January 2015, Pp 38-46
Christopher Lupfer | Ankit Malik | Thirumala Devi Kanneganti

Viral diseases of the central nervous system

Volume 11, Issue , 01 January 2015, Pp 44-54
Phillip A. Swanson | Dorian B. McGavern

The microbiome modulates arbovirus transmission in mosquitoes

Volume 15, Issue , 15 December 2015, Pp 97-102
Shivanand Hegde | Jason L. Rasgon | Grant L. Hughes

Thrips transmission of tospoviruses

Volume 15, Issue , 03 December 2015, Pp 80-89
Dorith Rotenberg | Alana L. Jacobson | Derek J. Schneweis | Anna E. Whitfield

Novel universal influenza virus vaccine approaches

Volume 17, Issue , 01 April 2016, Pp 95-103
Florian Krammer

Large T and small T antigens of Merkel cell polyomavirus

Volume 11, Issue , 01 January 2015, Pp 38-43
Justin A. Wendzicki | Patrick S. Moore | Yuan Chang

Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design

Volume 11, Issue , 01 January 2015, Pp 63-69
Max Crispin | Katie J. Doores

Recombination as a motor of host switches and virus emergence: Geminiviruses as case studies

Volume 10, Issue , 01 January 2015, Pp 14-19
Pierre Lefeuvre | Enrique Moriones

The evolution and emergence of hantaviruses

Volume 10, Issue , 01 January 2015, Pp 27-33
Edward C. Holmes | Yong Zhen Zhang

Emergence and dissemination of clade 2.3.4.4 H5Nx influenza viruses - How is the Asian HPAI H5 lineage maintained

Volume 16, Issue , 01 February 2016, Pp 158-163
Filip Claes | Subhash P. Morzaria | Ruben O. Donis

From virotherapy to oncolytic immunotherapy: Where are we now?

Volume 13, Issue , 29 June 2015, Pp 93-100
Robert S. Coffin

Engineering virus-like particles as vaccine platforms

Volume 18, Issue , 01 June 2016, Pp 44-49
Kathryn M. Frietze | David S. Peabody | Bryce Chackerian

BLT humanized mice as a small animal model of HIV infection

Volume 13, Issue , 15 June 2015, Pp 75-80
Marshall E. Karpel | Christian L. Boutwell | Todd M. Allen

Direct-acting antivirals: the endgame for hepatitis C?

Volume 24, Issue , 01 June 2017, Pp 31-37
Roberta D'Ambrosio | Elisabetta Degasperi | Massimo Colombo | Alessio Aghemo

Immune history and influenza virus susceptibility

Volume 22, Issue , 01 February 2017, Pp 105-111
Sarah Cobey | Scott E. Hensley

OASL - A new player in controlling antiviral innate immunity

Volume 12, Issue , 01 January 2015, Pp 15-19
Jianzhong Zhu | Arundhati Ghosh | Saumendra N. Sarkar

Approaches to preventative and therapeutic HIV vaccines

Volume 17, Issue , 01 April 2016, Pp 104-109
Glenda E. Gray | Fatima Laher | Erica Lazarus | Barbara Ensoli | Lawrence Corey

How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?

Volume 14, Issue , 01 October 2015, Pp 93-100
Charles R.M. Bangham | Lee Ratner